Aug 19, 2026 07:00AM

Aug 10, 2026 07:00AM

Aug 4, 2026 07:00AM

Jul 6, 2026 07:00AM

May 20, 2026 07:00AM

Mar 25, 2026 07:00AM

Mar 23, 2026 07:00AM Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building 

Oct 15, 2025 07:00AM

Oct 15, 2025 07:00AM

Sep 25, 2025 07:00AM

Sep 4, 2025 07:00AM

Sep 4, 2025 07:00AM

May 13, 2025 07:00AM

Jul 16, 2024 08:00AM Algernon Pharmaceuticals Reports Results of Study Showing 93% Cough Suppression with Ifenprodil

Mar 27, 2024 12:04PM

Nov 22, 2023 07:00AM

Jun 27, 2023 07:00AM

Jan 9, 2023 07:00AM

Dec 5, 2022 07:00AM

Sep 19, 2022 07:00AM

Sep 1, 2022 07:00AM Algernon Pharmaceuticals Reports Positive Results from Full Data Set of its Phase 2 Study of Ifenprodil for IPF and Chronic Cough

Jul 18, 2022 08:00AM

Feb 23, 2022 07:00AM

Jan 14, 2022 08:15AM

Dec 2, 2021 07:00AM

Nov 24, 2021 07:00AM

Oct 15, 2021 12:00PM

Oct 13, 2021 07:00AM Algernon Files Meeting Request with MHRA for Use of DMT in Phase 1/2a Human Stroke Study

Oct 8, 2021 07:00AM

Sep 22, 2021 07:30AM

Sep 20, 2021 07:00AM

Aug 11, 2021 07:00AM

Aug 9, 2021 07:00AM

Jul 6, 2021 08:30AM

Jun 3, 2021 07:00AM Algernon Pharmaceuticals Launches Pancreatic Cancer Clinical Research Program with Ifenprodil

May 17, 2021 07:00AM

Apr 26, 2021 08:07AM

Apr 26, 2021 08:00AM

Apr 8, 2021 07:00AM

Mar 31, 2021 08:00AM

Mar 17, 2021 07:00AM

Feb 19, 2021 08:00AM Algernon Pharmaceuticals Awards DMT Manufacturing Contract to Dalton Pharma for Stroke Program

Feb 1, 2021 07:30AM

Jan 7, 2021 08:00AM

Dec 30, 2020 08:00AM

Dec 17, 2020 08:00AM

Dec 15, 2020 08:15AM

Jun 25, 2020 08:00AM

Jun 4, 2020 12:10PM Algernon Receives U.S. FDA Clearance for Multinational Phase 2b/3 Human Study to Evaluate Ifenprodil as a Potential Therapeutic for COVID-19

May 26, 2020 08:49AM

330,180 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All